Callidus Software Inc. (CALD) recently announced a partnership with HAND Enterprise Solutions Company, a leading Chinese IT services company. Under the agreement, HAND will resell, implement and support Callidus Software’s sales performance management solutions in China.  Based in California , Callidus Software Inc. provides sales performance management (SPM) software and services in the United States and internationally. Its SPM systems are used to monitor and analyze sales performance and incentive compensation management programs. By partnering with HAND, Callidus will expand its footprint in the emerging market of China .  The partnership allows joint customers to rapidly implement and deploy Callidus Software's sales performance management solutions. As one of the fastest growing markets in the world, the demand for sales performance management solutions continues to rise in China due to the explosive growth of companies in sectors like telecommunications and financial services.  The company also announced that ...

 

PennyOmega.com Hot Stock News & Alerts!

________________________________________

FREE Daily Stock Alerts From PennyOmega.com

________________________________________

 

Friday September 4, 2009

PennyOmega.com Stock Report!

**************************************************************

Callidus Software Inc. (NASDAQ: CALD), the leader in Sales Performance Management (SPM), today announced that Medical Mutual of Ohio has selected Callidus Software’s Insurance Suite and Business Process Management Suite (BPM) to manage its sales performance, incentive compensation programs and broker onboarding processes. Under the agreement, signed in the third quarter

...

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

 

Tuesday August 18, 2009

PennyOmega.com Stock Report!

**************************************************************

Provectus Pharmaceuticals, Inc. (OTCBB:PVCT), a development-stage oncology and dermatology biopharmaceutical company, has added Mount Sinai School of Medicine as its second and final site for its expanded Phase 2 clinical trial of the Company’s lead dermatology agent PH-10 for psoriasis. Jason Emer, M.D. will serve as principal investigator of the trial; he is also the lead investigator for the Phase 2 clinical trial of PH-10 for atopic dermatitis, for which patient enrollment was completed in June.

Consistent with its ongoing efforts to enhance services offered to its customers and contract services clients, SouthWest Water Company (NASDAQ:SWWC), a leading provider of

...

For Immediate Release

Chicago, IL - May 5, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Palm (PALM), Hartford Financial Services Group, Inc. (HIG), Callidus Software, Inc. (CALD), Consolidated Edison (ED) and Washington Post Company (WPO).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Monday's Analyst Blog:

PALM: Hype & A Hot Stock

One of this year's hottest stocks has been Palm (PALM). Yes, the Palm that made PDA famous.

Last fall, shares of the company could have purchased for about $1.50 per share. On Friday,

...

Callidus Software: Losses Mount on Higher Q1 RevenuesShares of Callidus Software, Inc. (CALD, Hold) are off over 6% in trading today following the company's Q1 earnings release yesterday. Q1 revenues of $25.9 million was higher than our estimate of $25.2 million and consensus of $24.9 million, while non-GAAP EPS came in lower than expected. Q1 loss of $(0.05) per share was significantly lower than our and consensus estimate of a loss of $(0.02) per share. Callidus is one of the major providers of Enterprise Incentive Management (EIM) software systems. EIM software helps large enterprises across many industries determine and automate total compensation packages. Q1 revenue upside came mainly from the Services & Other segment, while recurring revenues came in line with expectation.The earning loss for the quarter, on the other hand, was mostly a result of the company's increased use of third-party vendors, which impacted gross ...